Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and Antiangiogenesis
Open Access
- 1 July 1998
- Vol. 9 (1), 25-34
- https://doi.org/10.1016/s1074-7613(00)80585-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- Other Kinases Can Substitute for Jak2 in Signal Transduction by Interferon-γJournal of Biological Chemistry, 1996
- Interaction between the Components of the Interferon γ Receptor ComplexJournal of Biological Chemistry, 1995
- Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.The Journal of Experimental Medicine, 1995
- Inhibition of Angiogenesis In Vivo by Interleukin 12JNCI Journal of the National Cancer Institute, 1995
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Regulation of human cytolytic lymphocyte responses by interleukin-12Cellular Immunology, 1992
- Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.The Journal of Experimental Medicine, 1989